Despite the rising competition in the obesity space, we believe that there is room for smaller biotechs like Viking Therapeutics to grab a share of this booming market.

The U.S. surgeon general has urged updating the label on alcoholic drinks to cite the increased risk of cancer.

The drug and biotech industry had a tough time in the past couple of months after Trump announced the appointment of Robert F ...

Elvis Presley released the song Stay Away in February of 1968 as part of the soundtrack for the movie Stay Away, Joe. This song only hit number 67 on the top 100 hits in the United States. This was ...

Arkansas was the first state to start sending letters home flagging students' Body Mass Index. Twenty years later, they do not appear to have had any effect on childhood obesity.

The United States was found to be a little bit thinner and healthier in 2023. Research findings show a decrease in obesity for the first time in a decade. Although this percentage is only 0.4%, it ...

Metsera, Inc., a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced positive data from a 12-week Phase 2a ...

The US Surgeon General released a report directly linking alcohol to cancer. A BI analysis of alcohol spending shows how ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

For the first time in a decade, body mass index and obesity prevalence in adults declined in the United States in 2023.

The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s.

Both reveal systemic biases against addressing obesity, the leading preventable health problem in the United States. Obesity is far more than a cosmetic concern. It’s a chronic disease.